Horner's Syndrome: an unusual ophthalmological presentation of Hodgkin lymphoma

Authors

  • C. Abascal Azanza Complejo Hospitalario de Navarra
  • R. Abarzuza Cortaire Complejo Hospitalario de Navarra
  • P. Plaza Ramos Complejo Hospitalario de Navarra

DOI:

https://doi.org/10.23938/ASSN.0117

Keywords:

Horner's Syndrome. Hodgkin lymphoma. Oculosympathetic pathway.

Abstract

Horner's Syndrome (HS) is a neurological syndrome characterised by the triad incomplete pupillary miosis, palpebral ptosis and facial anhidrosis, due to a lesion of the oculosympathetic pathway, formed of three neurons from the hipothalamus to the eye. Identifying its cause is a diagnostic challenge since in spite of its apparent lack of clinical importance, HS can be the first or only manifestation of a serious, or even potentially mortal disorder. We present the case of a 19-year-old male patient with a history of nonspecific ocular pains of two months evolution. He attended the emergency ophthalmological clinic where he was diagnosed with an HS as the first clinical manifestation of Hodgkin lymphoma.

Downloads

Download data is not yet available.

Author Biographies

C. Abascal Azanza, Complejo Hospitalario de Navarra

Residente de Oftalmología 3º en el Complejo Hospitalario de Navarra

R. Abarzuza Cortaire, Complejo Hospitalario de Navarra

Adjunta de Oftalmología en el Complejo Hospitalario de Navarra

P. Plaza Ramos, Complejo Hospitalario de Navarra

Residente de Oftalmología 3º en el Complejo Hospitalario de Navarra

References

SIMON SR, DORIGHI JA, BRANDA RF, ERSHLER WB. Horner's syndrome: an unusual presentation of Hodgkin's disease. Med Pediatr Oncol 1985; 13: 390-391.

KEANE JR. Oculosympathetic paresis. Analysis of 100 hospitalized patients. Arch Neurol 1979; 36: 13-15.

MALONEY WF, YOUNGE BR, MOYER NJ. Evaluation of the causes and accuracy of pharmacologic localization in Horner´s syndrome. Am J Ophthalmol 1980; 90: 394-402.

SMITH PG, DYCHES TJ, BURDE RM. Topographic analysis of Horner's syndrome. Otolaryngol Head Neck Surg 1986; 94: 451-457.

HARPE KG, ROTH RN. Horner's syndrome in the emergency department. J Emerg Med1990; 8: 629-634.

PATEL S, ILSEN PF. Acquired Horner's syndrome: clinical review. Optometry 2003; 74: 245-256.

ALMOG Y, GEPSTEIN R, KESLER A. Diagnostic value of imaging in Horner syndrome in adults. J neuroophthalmol 2010; 30: 7-11.

KARDON R. Are we ready to replace cocaine with apraclonidine in the pharmacologic diagnosis of Horner syndrome? J neuroophthalmol 2005; 25: 69-70.

MORALES J, BROWN SM, ABDUL-RAHIM AS, CROSSON CE. Ocular effects of apraclonidine in Horner syndrome. Arch Ophthalmol. 2000; 118: 951-954.

FREEDMAN KA, BROWN SM. Topical apraclonidine in the diagnosis of suspected Horner syndrome. J neuroophthalmol 2005; 25: 83-85.

DAVAGNANAM I, FRASER CL, MISZKIEL K, DANIEL CS, PLANT GT. Adult Horner's syndrome: a combined clinical, pharmacological, and imaging algorithm. Eye (Lond) 2013; 27: 291-298.

CHEN Y, MORGAN ML, BARROS PALAU AE, YALAMANCHILI S, LEE AG. Evaluation and neuroimaging of the Horner syndrome. CJO 2015; 50: 107-111.

Published

2017-12-29

How to Cite

1.
Abascal Azanza C, Abarzuza Cortaire R, Plaza Ramos P. Horner’s Syndrome: an unusual ophthalmological presentation of Hodgkin lymphoma. An Sist Sanit Navar [Internet]. 2017 Dec. 29 [cited 2025 Dec. 22];40(3):461-6. Available from: https://recyt.fecyt.es/index.php/ASSN/article/view/57625

Issue

Section

Clinical notes

Most read articles by the same author(s)

Similar Articles

1 2 3 4 5 6 7 8 9 10 > >> 

You may also start an advanced similarity search for this article.